High-performance thin-layer chromatographic determination of N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in urine and comparison with high-performance liquid chromatography
- 10 January 1997
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 688 (1) , 63-69
- https://doi.org/10.1016/s0378-4347(97)88056-5
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, “Eve”) and its metabolites in urine by gas chromatography — mass spectrometry and fluorescence polarization immunoassayJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Psychological Effects of MDE in Normal SubjectsNeuropsychopharmacology, 1993
- Synthetische Suchtstoffe der 2. Generation (sog. Designer Drugs) 1. Mitt.: Amphetamine und andere ArylalkanaminePharmazie in unserer Zeit, 1990
- In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detectorChemical Research in Toxicology, 1988
- Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)Journal of Pharmaceutical Sciences, 1980